Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Nabi files for European approval of Nabi-HB Intravenous

July 1, 2004

Complete NDA submitted for Entereg in POI

June 30, 2004

Singapore study for Dynavax HBV prophylactic vaccine

June 29, 2004

Novel synthetic glycolipid promising against hepatitis B and C viruses

June 28, 2004

Novel HCV NS5B inhibitors jointly reported by ViroPharma and Wyeth

June 25, 2004

FDA approves Rapinex powder for oral suspension 20 mg

June 18, 2004

Daily Infergen plus ribavirin evaluated for HCV in new DIRECT trial

June 17, 2004

Vertex and Mitsubishi sign agreement for VX-950 in Japan and Far East

June 16, 2004

Second of two phase III trials for Viramidine under way

June 16, 2004

VX-950 enters phase I for HCV

June 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...